Cannabis Investment Report – Projected International Legal Market Values (Dec 2017)
Summary
The passage provides market size estimates for legal cannabis markets worldwide. It contains no references to political figures, government agencies, financial misconduct, or illicit flows. While it c Lists projected market values for 20+ countries based on 20% penetration and spending estimates. Sources data from Ackrell Capital, a FINRA‑registered firm. Includes adult population and average mont
This document is from the House Oversight Committee Releases.
View Source CollectionPersons Referenced (2)
Tags
Related Documents (6)
Ackrell Capital Cannabis Investment Report compares market size to alcohol, coffee, tobacco, and pharmaceuticals
The document is a commercial investment analysis with no mention of political figures, government agencies, or alleged misconduct. It offers no actionable leads for investigations and contains only pu Provides estimated penetration rates and consumer spending for cannabis versus other legal substance Claims U.S. legal cannabis market size aligns with other retail markets. Published by Ackrell Capi
Industry overview of cannabis and hemp companies with revenue and partnership details
The passage provides commercial financial metrics and partnership information for several cannabis‑related firms. It contains no references to high‑ranking officials, government agencies, or illicit a GTI reports $41.7 M revenue with >300% YoY growth. Khiron Life Sciences entered a 50/50 JV with U.S. Dixie Brands for Latin American CBD cosmetics. Level Brands acquired CBD consumer brand cbdMD, gen
Ackrell Capital Cannabis Investment Report (Dec 2017) – Canadian Stock Market Comparison
The document is a routine market analysis with no mention of high‑profile individuals, government agencies, or controversial transactions. It provides generic data on exchange listings and financial c Shows that >10% of Canadian Securities Exchange listings are cannabis‑related. Compares market size and median company values across TSX, TSXV, and CSE. Outlines listing and governance requirements f
Cannabis Investment Report – Private Company Funding Totals (2016‑2017 YTD)
The document lists aggregate capital raised by private cannabis‑related firms and a few deal specifics. It contains no references to high‑ranking officials, government agencies, foreign leaders, or al Total capital raised by private cannabis companies grew from $256 M in 2016 to $483 M YTD 2017. Number of deals increased from 65 to 102 in the same period. Largest disclosed private deals in 2017 we
Cannabis Investment Report – Ackrell Capital (Dec 2017) – Product Overview
The passage is a marketing‑style product description of cannabis flower and concentrates. It contains no references to political figures, government agencies, financial misconduct, or foreign influenc Describes cannabis flower characteristics and typical THC/CBD levels. Lists popular strain names and concentrate types. Claims 100% pesticide‑free product and FINRA/SIPC membership.
Cannabis Investment Report – December 2017 Overview of Distribution and Regulatory Landscape
The passage is a generic industry analysis without specific names, transactions, dates, or concrete allegations involving high‑profile officials or entities. It offers only broad context about tax and Highlights tax compliance risks for cannabis distributors across U.S. states. Notes potential market saturation and licensing moratoriums in Colorado. Mentions California’s new cannabis regulatory ag
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.